Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

AstraZeneca

AstraZeneca

Rank: 9

2022 Rank: 11

Cambridge, United Kingdom
www.astrazeneca.com

2022 Revenues ($USD) : $44,351,000,000.00
2022 R&D spend : $9,762,000,000.00
2022 Number of Employees : 83,500
Fiscal Year End : 12/31/22
Leader : CEO Pascal Soriot

The Cambridge, U.K.–headquartered global biopharmaceutical company reported strong financial performance in 2022, with total revenue reaching $44.4 billion, a 25% increase at constant exchange rates. Earnings per share for the year were $6.66, a 33% increase compared to the prior year. The company's diverse product portfolio and broad geographic footprint supported its growth. In 2022, AstraZeneca reported eight positive phase 3 readouts and 34 regulatory approvals in key markets. The company plans to initiate over 30 additional phase 3 studies in 2023, with 10 trials having blockbuster potential. AstraZeneca aims to launch at least 15 new medicines by the end of the decade, targeting industry-leading revenue growth in the long term. The company's 2023 guidance projects a high single-digit to low double-digit percentage increase in core EPS, anticipating a substantial decline in demand for COVID medicines. —BB
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE